Day: February 26, 2026

VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discoveries, is pleased to announce the successful completion and expiry of its Warrant Acceleration Program (the “Acceleration”) of outstanding common share purchase Warrants of the Company issued in connection with a financing that closed in two tranches on May 23 and July 31, 2025 (the “May Financing”) and a financing that closed on October 10, 2025 (the “October Financing”; together with the May Financing, the “Financings”). The Company issued an aggregate of 6,637,667 warrants and 163,146 finder’s warrants (together, the “May Warrants”) in connection with the May Financing. The Company also issued...

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow based on the unbiased, genome-wide approach of optical genome...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — StoneX Group Inc. (“StoneX”; NASDAQ: SNEX) today announced that StoneX Digital, a division of StoneX, has launched a digital asset lending capability, expanding the firm’s existing brokerage and financing services for institutional clients. StoneX Digital connects institutional clients to digital asset markets through spot execution, listed products, such as exchange-traded funds and futures, and financing solutions within a single institutional framework. The introduction of this lending capability extends those services and aims to support clients seeking additional liquidity and capital efficiency while maintaining exposure to digital assets within broader trading and investment strategies. Institutional market participants increasingly require financing tools that align with both digital...

Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased organizational discipline Strong revenue outlook, procedure growth, expanding margins, and path to profitability Longer-term growth drivers include market expansion and expanded application into prostate cancerNEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today hosted its 2026 Investor Day event in New York to detail the Company’s market opportunity, long-term strategy and growth goals, and 2026 – 2027 financial guidance. During the event, PROCEPT executive team members outlined the large, underpenetrated opportunity...

JENA, Germany, Feb. 26, 2026 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in the Leerink Partners Global Healthcare Conference. Details are as follows: Leerink Partners Global Healthcare ConferenceMarch 8 – 11, 2026 in Miami, FLFireside chat on March 9 at 9:20 AM ET InflaRx will also conduct one-on-one investor meetings on March 9th. A link to view the fireside chat live stream and its replay is available here. About InflaRxInflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation...

COLUMBUS, Ohio, Feb. 26, 2026 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) today announced that its Board of Directors (the “Board”) has approved a $600 million increase to the Company’s existing share repurchase authorization. As of December 31, 2025, the Company had $240 million remaining on its open share repurchase authorization. The Company made an additional $75 million of repurchases to-date during 2026, meaning that $165 million of share repurchase capacity was available prior to today’s announcement. After today’s announcement, the Company’s share repurchase authorization is currently $765 million. There is no expiration date for the share repurchase authorization. “Today’s announcement continues to underscore our ability to execute all of our capital and growth priorities...

Giant Containers to design and build critical infrastructure and community amenities for transformative urban state park spanning northern New Jersey CONROE, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) — via IBN — Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox Industries” or the “Company”) today announced that its subsidiary, Giant Containers, has been selected to provide design and construction services for critical infrastructure and amenities as part of the nearly one-mile Newark segment of New Jersey’s newest state park. The park is envisioned to be a nine-mile greenway and multi-use corridor connecting eight communities in Essex and Hudson counties in northeastern New Jersey. The initiative envisions repurposing a long-abandoned railroad right of way into a linear state park traversing the New Jersey Meadowlands, spanning the Hackensack...